BOSTON, Feb. 28, 2025 /PRNewswire/ -- Magnet Biomedicine, a leading biopharmaceutical company advancing molecular glue discovery with rational selection and design, today announced a collaboration and ...
GlobalData on MSN
Magnet Biomedicine and Lilly link for molecular glue therapeutics
Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise ...
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop and commercialize molecular glue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback